Amitriptyline/chlordiazepoxide

Amitriptyline/chlordiazepoxide, sold under the brand names Limbitrol and Limbitrol DS, is a combination of amitriptyline (Elavil), a tricyclic antidepressant, and chlordiazepoxide (Librium), a benzodiazepine, which is approved for the treatment of moderate to severe depression associated with moderate to severe anxiety in the United States.[1][2] It contains 12.5 to 25 mg amitriptyline and 5 to 10 mg chlordiazepoxide per tablet.[1][2]

Amitriptyline/chlordiazepoxide
Amitriptyline (top) and chlordiazepoxide (bottom)
Combination of
AmitriptylineTricyclic antidepressant
ChlordiazepoxideBenzodiazepine
Clinical data
Trade namesLimbitrol, Limbitrol DS
Routes of
administration		Oral
Legal status
Legal status
  • In general: ℞ (Prescription only)

References
  1. Mylan Pharmaceuticals Inc. (May 2014). "Chlordiazepoxide and Amitriptyline Tablets Label" (PDF). U.S. Food and Drug Administration.
  2. Townsend MC, Morgan KI (9 January 2018). Pocket Guide to Psychiatric Nursing. F.A. Davis. pp. 443–. ISBN 978-0-8036-7705-0. OCLC 1019871725.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.